- Report
- January 2025
- 153 Pages
Global
From €5682EUR$5,950USD£4,752GBP
- Report
- March 2025
- 291 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Clinical Trials
- August 2024
- 80 Pages
Global
From €1910EUR$2,000USD£1,597GBP
- Report
- October 2024
- 58 Pages
Global
From €3815EUR$3,995USD£3,191GBP
- Report
- May 2024
- 133 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- May 2024
- 131 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1433EUR$1,500USD£1,198GBP
- Report
- August 2022
- 116 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- January 2022
- 200 Pages
Global
From €7163EUR$7,500USD£5,990GBP
- Report
- January 2022
- 60 Pages
Global
From €3772EUR$3,950USD£3,155GBP
- Report
- November 2023
- 157 Pages
Global
From €2388EUR$2,500USD£1,997GBP
- Report
- January 2022
- 110 Pages
Global
From €4536EUR$4,750USD£3,794GBP
- Report
- November 2021
- 177 Pages
Global
From €14321EUR$14,995USD£11,976GBP
- Report
- May 2022
- 188 Pages
Global
From €2388EUR$2,500USD£1,997GBP
- Report
- May 2022
- 44 Pages
Global
From €1910EUR$2,000USD£1,597GBP

The Sepsis Drug market is a subset of the larger Infectious Diseases Drugs market. Sepsis is a life-threatening condition caused by the body's response to an infection. It is a major cause of death worldwide, and the drugs used to treat it are an important part of the Infectious Diseases Drugs market. Sepsis drugs are typically antibiotics, antifungals, antivirals, and other immunomodulators. These drugs are used to reduce the severity of the infection and to prevent further complications.
The Sepsis Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Johnson & Johnson. Other companies such as Novartis, Bristol-Myers Squibb, and Eli Lilly also have a presence in the market. Show Less Read more